# Early Changes in Renal Function as Predictors of In-Hospital Mortality in COVID-19 Patients

**Authors:** Nicu Olariu, Nilima Rajpal Kundnani, Simona Ruxanda Dragan, Luciana-Elena Marc, Victor Buciu, Delia Mira Berceanu Vaduva, Andreas Valcovici, Ioana Adela Ratiu, Petru Bucuras, Adelina Mihaescu

PMC · DOI: 10.3390/life16020331 · 2026-02-14

## TL;DR

This study shows that early changes in kidney function within the first 48 hours of hospitalization for COVID-19 can predict in-hospital mortality better than static kidney measures.

## Contribution

The study introduces a novel approach using dynamic early kidney function patterns to improve risk stratification in hospitalized COVID-19 patients.

## Key findings

- Early improvement in kidney function was associated with higher in-hospital mortality compared to stable function.
- Early deterioration in kidney function showed a similar trend but was not statistically significant.
- Early improvement was linked to higher AKI burden and increased need for hemodialysis.

## Abstract

Background: Acute kidney injury (AKI) is a frequent and prognostically relevant complication of COVID-19. However, reliance on static creatinine values or binary AKI definitions may overlook clinically meaningful early renal dynamics. We evaluated whether early renal function trajectories within the first 24–48 h of hospitalization provide incremental prognostic information. Methods: We conducted a retrospective, single-center cohort study of adults hospitalized with laboratory-confirmed COVID-19 between December 2020 and December 2021. Early renal function patterns were defined using KDIGO-based changes in serum creatinine between admission and 24–48 h, classifying patients as stable, early improvement, or early deterioration. The primary outcome was in-hospital mortality. Multivariable logistic regression adjusted for age, sex, chronic kidney disease, comorbidities, inflammatory burden (C-reactive protein), nutritional status (albumin), pulmonary involvement, and treatment variables. Results: Among 721 patients, 65.2% had stable renal function, 22.5% had early improvement, and 12.3% had early deterioration. In-hospital mortality differed significantly across dynamic patterns (p = 0.007). Mortality was lowest in the stable group (35.1%) and higher in both early improvement (48.1%) and early deterioration (44.9%). After multivariable adjustment, early improvement remained independently associated with higher in-hospital mortality compared with stable renal function (adjusted OR 1.53, 95% CI 1.03–2.28), while early deterioration showed a directionally similar but non-significant association. Early improvement was also associated with higher AKI burden and increased need for acute de novo hemodialysis. Conclusions: Early renal function change patterns within the first 24–48 h of hospitalization carry prognostic value beyond static creatinine measures. Apparent early creatinine improvement may reflect recovery from prior injury or systemic instability rather than true renal recovery, identifying a subgroup at heightened risk. Classification based on early renal function assessment may enhance early risk stratification in hospitalized patients with COVID-19.

## Linked entities

- **Diseases:** acute kidney injury (MONDO:0002492), COVID-19 (MONDO:0100096)

## Full-text entities

- **Genes:** TIMP2 (TIMP metallopeptidase inhibitor 2) [NCBI Gene 7077] {aka CSC-21K, DDC8}, HAVCR1 (hepatitis A virus cellular receptor 1) [NCBI Gene 26762] {aka CD365, HAVCR, HAVCR-1, KIM-1, KIM1, TIM}, IGFBP7 (insulin like growth factor binding protein 7) [NCBI Gene 3490] {aka AGM, FSTL2, IBP-7, IGFBP-7, IGFBP-7v, IGFBPRP1}, LCN2 (lipocalin 2) [NCBI Gene 3934] {aka 24p3, MSFI, NGAL, p25}, CRP (C-reactive protein) [NCBI Gene 1401] {aka PTX1}, ALB (albumin) [NCBI Gene 213] {aka FDAHT, HSA, PRO0883, PRO0903, PRO1341}
- **Diseases:** respiratory failure (MESH:D012131), multi-organ dysfunction (MESH:D009102), obesity (MESH:D009765), azotemia (MESH:D053099), AKI (MESH:D058186), hypoalbuminemia (MESH:D034141), venous congestion (MESH:D006940), baseline renal reserve (MESH:D006030), systemic disease (MESH:D034721), injury to (MESH:D014947), comorbidity (MESH:D004194), inflammation (MESH:D007249), critically ill (MESH:D016638), Pulmonary involvement (MESH:C566343), muscle (MESH:D019042), mitochondrial dysfunction (MESH:D028361), oliguria (MESH:D009846), endothelial dysfunction (MESH:D014652), morbid (OMIM:614963), lung damage (MESH:D008171), diabetes (MESH:D003920), tubular damage (MESH:D000230), anuria (MESH:D001002), Chronic kidney disease (MESH:D051436), kidney injury (MESH:D007674), coronary artery disease (MESH:D003324), systemic (MESH:D015619), microvascular dysfunction (MESH:D017566), FRA-COVID (MESH:C536253), hypertension (MESH:D006973), Death (MESH:D003643), cardiovascular disease (MESH:D002318), CKD (MESH:D012080), renal congestion (MESH:D002311), COVID-19 (MESH:D000086382), atrial fibrillation (MESH:D001281), end-stage kidney disease (MESH:D007676), dehydration (MESH:D003681), endothelial injury (MESH:D057772), insulin resistance (MESH:D007333)
- **Chemicals:** favipiravir (MESH:C462182), remdesivir (MESH:C000606551), Creatinine (MESH:D003404), potassium (MESH:D011188), sodium (MESH:D012964), urea (MESH:D014508), fatty acid (MESH:D005227)
- **Species:** Severe acute respiratory syndrome coronavirus 2 (no rank) [taxon 2697049], Homo sapiens (human, species) [taxon 9606]

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12941961/full.md

---
Source: https://tomesphere.com/paper/PMC12941961